The Apple Watch may soon introduce a new feature for sensing blood pressure.
Apple's new blood pressure notification feature is currently under FDA review.
Apple Watches already provide hypertension notifications, but the tech giant is reportedly developing a new blood pressure-related feature that goes beyond the existing alert system.
According to Digitimes, this high blood pressure notification feature is being evaluated by the U.S. Food and Drug Administration. However, this wording is somewhat complex, as Apple introduced hypertension notifications back in September 2025 with watchOS 26. This feature is compatible with Apple Watch Series 9 and newer, as well as Apple Watch Ultra 2 and Ultra 3, in certain regions.
How will blood pressure alerts function?
It remains unclear how this new blood pressure feature will differ from what Apple currently offers. The report indicates that the anticipated high-end 2026 watch, presumably the upcoming Watch Ultra 4, may undergo a redesign and incorporate enhanced health sensors. If true, this would be the first significant health sensor upgrade for the Apple Watch since the Series 8. The new blood pressure feature could rely on this upgraded hardware, but that is merely speculation at this time.
Apple's existing hypertension notifications are intended more as an early warning mechanism than a diagnostic tool. This feature monitors trends over a 30-day span and alerts users if it identifies indications of chronic high blood pressure. It received FDA approval in September 2025. Apple states that the feature utilizes heart sensor data and machine learning, but it does not measure blood pressure directly or serve as a substitute for a medical-grade cuff.
What might follow?
Apple's aspirations in the health sector extend beyond blood pressure. The company has also been associated with noninvasive blood glucose monitoring for several years, a concept that would utilize light-based sensors to estimate glucose levels without the need for a finger prick or blood sample. However, achieving accuracy in a smartwatch format is quite challenging, so for now, the forthcoming blood pressure notifications appear to be a more feasible next step for the Apple Watch.
Other articles
Google I/O 2026: Anticipations for Gemini, Android 17, and additional updates
Google I/O 2026 is anticipated to emphasize Gemini AI, Android 17, smart devices, and Google's overall transition to an AI-first ecosystem.
PlayStation Plus is increasing in price just as everyone is returning.
Sony's recent increase in PS Plus pricing affects monthly and three-month subscribers, just ahead of the anticipated release of GTA 6, which is likely to draw a surge of players back to online multiplayer.
Barclays reports that humanoid robots could help alleviate 60% of the anticipated 37 million worker shortage in China by 2035.
Barclays states that China's introduction of humanoid robots could compensate for nearly 60% of the anticipated decline of 37 million workers in the labor force by 2035, necessitating the use of up to 24 million humanoid robots.
Sony no longer aims for “PlayStation exclusive” games to be released on PC.
According to reports, Sony is reducing its PC releases of significant single-player PlayStation titles, indicating a considerable change in strategy following years of growth in the PC market.
Moonshot, the developer of Kimi, has decided to abandon its VIE structure for its listing in Hong Kong, with a valuation of $20 billion.
Moonshot AI, the $20 billion Beijing-based creator of the Kimi chatbot, has notified its shareholders that it plans to eliminate its offshore VIE structure to facilitate a Hong Kong IPO in accordance with the new CSRC regulations.
Hypershell secures an additional $50 million in a $120 million Series B round as consumer exoskeletons move beyond a niche market.
Hypershell has secured $50 million in a Series B+ round co-led by Ant Group and Meituan Dragonball, with Sofina and Granite Asia participating as well. The total funding for the Series B has reached $120 million, valuing the company at nearly $400 million ahead of the X-Series launch on Wednesday.
The Apple Watch may soon introduce a new feature for sensing blood pressure.
The Apple Watch currently alerts users regarding potential hypertension, but Apple could be developing a more sophisticated blood pressure function for its upcoming premium model.